Chinese expert consensus on patient-controlled intravenous analgesia for cancer pain

Abstract

Patient-controlled intravenous analgesia (PCIA) is a common form of individualized treatment for cancer pain, and it has the characteristics of rapid onset, stable blood concentration and on-demand administration, which is suitable for patients who fail to take oral medicine or have poor pain control with oral medications. The preferred drugs for PCIA are strong opioids, which can be combined with sedative drugs according to the patient's condition. Dose titration is required prior to administration of PCIA, dynamic pain assessment should be performed during the use of PCIA, the dose should be adjusted at any time, and the adverse reactions should be closely monitored and treated in time. When pain control is stable, it can be transferred to home treatment. Therefore, PCIA has broad application prospects in patients with cancer pain due to its advantages of simple operation, relatively easy nursing care and controllable risk.